Subscribe to Specialty Providers

Specialty Providers

For financial health, don't neglect business side of operations

 - 
04/24/2017

By the time David Franklin is brought on as a consultant, the company in question is often in dire need of a turnaround, he says.

Infusion conference looks 'homeward'

 - 
04/24/2017

ORLANDO, Fla. – Health care is “going home” and the upcoming National Home Infusion Association’s annual conference aims to help attendees plan for that future, say organizers.

Arriva Medical in ‘midst’ of ALJ appeal

Acquisition by Abbott Laboratories moves forward
 - 
04/21/2017

CORAL SPRINGS, Fla. – Arriva Medical, a provider of diabetes testing supplies, remains confident that it will get its Medicare billing status reinstated.

Abbott Labs, Alere deal moves forward

 - 
04/18/2017

ABBOTT PARK, Ill., and WALTHAM, Mass. – Abbott Laboratories has agreed to buy Alere, but at a lower price than it previously offered.

Survey: Mail-order program reduces access

 - 
03/30/2017

CHICAGO – Medicare’s national mail-order program for diabetes testing supplies has sharply reduced beneficiary access, says a new survey from the America Association of Diabetes Educators.

The “secret shopper” survey found that:   

Keeping Pace with new CEO at MedBridge

 - 
03/27/2017

Throughout his long healthcare career, Ghentry Pace has seen the direct correlation between quality patient care and strong financial performance.

Lymphedema advocates leverage personal connections

‘During these meetings, the light goes on,’ Woodward says
 - 
03/24/2017

WASHINGTON – With recently reintroduced legislation in hand, more than 70 lymphedema advocates will visit Capitol Hill this week to build on previous support.

'Clear mission' says Greenleaf

 - 
03/22/2017

With one full financial quarter under his belt, BioScrip President and CEO Dan Greenleaf says the company is reinvigorated and on track to right itself.

CCS Medical ‘Connects’ diabetes patients

‘We never dismiss or discharge anyone’
 - 
03/17/2017

FARMERS BRANCH, Texas – CCS Medical is seeing 25% higher testing rates for hemoglobin A1c, blood pressure, cholesterol, kidney and eye tests, and reductions in emergency room visits and hospitalizations for patients in its virtual diabetes education program.

CORE is key to BioScrip reversal

 - 
03/10/2017

DENVER – BioScrip has pushed closer to its goal of having its core home infusion business make up 85% of its overall revenue, said company executives on a recent earnings call.

Pages